Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia
Pegfilgrastim (Neulasta) is a recombinant filgrastim (human granulocyte colony-stimulating factor (G-CSF)) attached to a polyethylene glycol (PEG) molecule and is given as part of chemotherapy regimens that are associated with significant myelosuppression and risk for febrile neutropenia. Prescribin...
Saved in:
Main Authors: | Pashtoon Murtaza Kasi, Mrinal M. Patnaik, Prema P. Peethambaram |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2013/146938 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Use of Intravenous Neostigmine in Palliation of Severe Ileus
by: Pashtoon Murtaza Kasi
Published: (2013-01-01) -
Malignant Hyperthermia and Idiopathic HyperCKemia
by: Pashtoon Murtaza Kasi
Published: (2011-01-01) -
Pentazocine and zolpidem addiction in a sickle cell anemia patient
by: Mandakini Bhowmick, et al.
Published: (2024-12-01) -
The endocannabinoid system’s genetic polymorphisms in sickle cell anemia patients
by: Amanda Cristina Meneguetti Berti, et al.
Published: (2024-12-01) -
Sickling Cells, Cyclic Nucleotides, and Protein Kinases: The Pathophysiology of Urogenital Disorders in Sickle Cell Anemia
by: Mário Angelo Claudino, et al.
Published: (2012-01-01)